arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2602.11237cs.LGcs.AI
收藏

基于人工智能的临床决策支持系统用于增强糖尿病诊断与管理

AI-Driven Clinical Decision Support System for Enhanced Diabetes Diagnosis and Management

De Montfort University(德蒙福特大学)

Mujeeb Ur Rehman, Imran Rehan, Sohail Khalid

AI总结:

本文提出了一种基于人工智能的临床决策支持系统,用于高精度诊断2型糖尿病,其在预测糖尿病、糖尿病前期和高风险个体方面表现出极高的准确性。

摘要:

识别2型糖尿病具有挑战性,尤其是对初级保健医生而言。结合人工智能(AI-CDSS)的临床决策支持系统可以帮助医疗专业人员以高精度诊断2型糖尿病。本研究旨在评估专门用于2型糖尿病诊断的AI-CDSS,该系统采用混合方法,整合专家驱动的见解与机器学习技术。AI-CDSS使用包含1298名有无2型糖尿病患者的数据集进行开发(训练数据集:n=650)和测试(测试数据集:n=648)。为了生成预测,算法利用了关键特征,如体重指数、血浆空腹血糖和血红蛋白A1C。此外,还进行了一项涉及105名患者的临床试点研究,以评估系统在与非内分泌科专家比较时的诊断准确性。AI-CDSS显示出高准确性,预测糖尿病的准确率为99.8%,预测糖尿病前期的准确率为99.3%,识别高风险个体的准确率为99.2%,预测无糖尿病的准确率为98.8%。测试数据集显示,内分泌科专家与AI-CDSS之间的一致性为98.8%。在试点研究中,45%的105名个体被识别出2型糖尿病。与糖尿病专家相比,AI-CDSS的符合率为98.5%,远高于非内分泌科专家的85%。这些发现表明,AI-CDSS有潜力成为准确识别2型糖尿病的有用工具,尤其是在糖尿病专家不可用的情况下。

英文摘要:

Identifying type 2 diabetes mellitus can be challenging, particularly for primary care physicians. Clinical decision support systems incorporating artificial intelligence (AI-CDSS) can assist medical professionals in diagnosing type 2 diabetes with high accuracy. This study aimed to assess an AI-CDSS specifically developed for the diagnosis of type 2 diabetes by employing a hybrid approach that integrates expert-driven insights with machine learning techniques. The AI-CDSS was developed (training dataset: n = 650) and tested (test dataset: n = 648) using a dataset of 1298 patients with and without type 2 diabetes. To generate predictions, the algorithm utilized key features such as body mass index, plasma fasting glucose, and hemoglobin A1C. Furthermore, a clinical pilot study involving 105 patients was conducted to assess the diagnostic accuracy of the system in comparison to non-endocrinology specialists. The AI-CDSS showed a high degree of accuracy, with 99.8% accuracy in predicting diabetes, 99.3% in predicting prediabetes, 99.2% in identifying at-risk individuals, and 98.8% in predicting no diabetes. The test dataset revealed a 98.8% agreement between endocrinology specialists and the AI-CDSS. Type 2 diabetes was identified in 45% of 105 individuals in the pilot study. Compared with diabetes specialists, the AI-CDSS scored a 98.5% concordance rate, greatly exceeding that of nonendocrinology specialists, who had an 85% agreement rate. These findings indicate that the AI-CDSS has the potential to be a useful tool for accurately identifying type 2 diabetes, especially in situations in which diabetes specialists are not readily available.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑